Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $247.61 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $92.18 | 4 | $0 (2022) |
| ABBVIE INC. | $88.05 | 6 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $36.02 | 2 | $0 (2023) |
| Pear Therapeutics (US), Inc. | $18.89 | 1 | $0 (2022) |
| Hologic, LLC | $12.47 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.11 | 1 | Janssen Pharmaceuticals, Inc ($19.11) |
| 2022 | $116.79 | 6 | Indivior Inc. ($44.34) |
| 2021 | $51.40 | 4 | AbbVie Inc. ($51.40) |
| 2018 | $60.31 | 3 | Indivior Inc. ($47.84) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Neuroscience | ||||||
| 05/17/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: OUD | ||||||
| 05/03/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: VIROLOGY | ||||||
| 03/22/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: VIROLOGY | ||||||
| 03/11/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: OUD | ||||||
| 02/08/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Neuroscience | ||||||
| 01/31/2022 | Pear Therapeutics (US), Inc. | reSET (Device) | Food and Beverage | Cash or cash equivalent | $18.89 | General |
| Category: Prescription Digital Therapeutics | ||||||
| 11/16/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: VIROLOGY | ||||||
| 08/12/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: VIROLOGY | ||||||
| 07/22/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: VIROLOGY | ||||||
| 04/29/2021 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: VIROLOGY | ||||||
| 05/15/2018 | Hologic, LLC | AC2 (Device) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Diagnostics | ||||||
| 05/08/2018 | Indivior Inc. | SUBLOCADE (Drug), SUBOXONE SUBLINGUAL FILM | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: OUD | ||||||
| 01/04/2018 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: OUD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 160 | 270 | $45,011 | $13,378 |
| 2022 | 4 | 83 | 159 | $28,202 | $10,046 |
| 2021 | 9 | 217 | 436 | $45,048 | $20,135 |
| 2020 | 6 | 135 | 425 | $42,627 | $15,296 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 113 | $25,489 | $7,261 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 48 | $14,352 | $3,930 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $2,945 | $992.46 | 33.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 18 | $720.00 | $529.02 | 73.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 15 | 16 | $528.00 | $327.69 | 62.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 25 | 31 | $527.00 | $260.40 | 49.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 13 | 25 | $450.00 | $77.30 | 17.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 84 | $18,648 | $6,466 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 30 | $8,820 | $3,439 | 39.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 12 | 31 | $510.00 | $99.59 | 19.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 14 | $224.00 | $41.46 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 122 | $26,812 | $10,782 | 40.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 24 | $6,986 | $2,996 | 42.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 29 | $4,314 | $1,413 | 32.8% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 34 | 34 | $1,360 | $1,287 | 94.6% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 28 | 28 | $1,120 | $1,060 | 94.6% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 26 | 26 | $1,040 | $984.10 | 94.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 16 | 63 | $1,323 | $706.86 | 53.4% |
| 0064A | Fee covid-19 vac 7 res | Office | 2021 | 16 | 16 | $640.00 | $605.60 | 94.6% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 22 | 94 | $1,453 | $300.67 | 20.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 137 | $29,622 | $10,539 | 35.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 58 | $8,543 | $2,704 | 31.7% |
| 80305 | Testing for presence of drug | Office | 2020 | 23 | 121 | $2,541 | $1,504 | 59.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 15 | 16 | $560.00 | $256.96 | 45.9% |
| 96127 | Brief emotional or behavioral assessment | Office | 2020 | 15 | 77 | $1,121 | $244.33 | 21.8% |
About Dr. Michael Vizachero, M.D
Dr. Michael Vizachero, M.D is a Family Medicine healthcare provider based in Shelbyville, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1164834818.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Vizachero, M.D has received a total of $247.61 in payments from pharmaceutical and medical device companies, with $19.11 received in 2023. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($247.61).
As a Medicare-enrolled provider, Vizachero has provided services to 595 Medicare beneficiaries, totaling 1,290 services with total Medicare billing of $58,855. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Shelbyville, MI
- Active Since 05/29/2014
- Last Updated 11/19/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1164834818
Products in Payments
- MAVYRET (Drug) $88.05
- SUBLOCADE (Drug) $63.73
- SPRAVATO (Drug) $36.02
- SUBOXONE SUBLINGUAL FILM (Drug) $28.45
- reSET (Device) $18.89
- AC2 (Device) $12.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shelbyville
Dr. Ron Creque, Md, MD
Family Medicine — Payments: $15,710
Paul Goodlett, Md, MD
Family Medicine — Payments: $14,867
Dr. David Oligschlaeger, D.o, D.O
Family Medicine — Payments: $11,457
Beth Buchanan, Md, MD
Family Medicine — Payments: $10,835
Dr. Emily Ann Andaya, Md, MD
Family Medicine — Payments: $8,149
Meredith Kehrer, Md, MD
Family Medicine — Payments: $6,265